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Introduction: Cutaneous mast cell tumour (MCT) Patnaik and
Kiupel grading schemes rely on qualitative and semiquantitative fea-
tures susceptible to interobserver variability. Stereological estimation
of volume-weighted mean nuclear volume (MNV) provides informa-
tion about both size and variability of nuclear size, which has been
proven to have a prognostic value in other solid tumours. The objec-
tive was to compare MNV with MCT grade and biological
behaviour.
Materials and Methods: Fifty-six MCTs were graded according to
Patnaik and Kiupel by consensus of three experienced pathologists.
Clinical history of dogs treated with surgical excision alone was
collected with a minimum follow-up period of 1 year (n 5 31).
MNV was estimated using the point-intercept method on vertical sec-
tions in 10 microscopical fields, with an approximately constant dis-
tance proportional to overall sectional area. Animals were divided
according to outcome: group 1, no recurrence; group 2, local recur-
rence, lymph node or distant metastasis. Statistical analyses of results
were performed by the ManneWhitney U Test and receiver oper-
ating characteristics (ROC) curve.
Results: MNV of low grade (n 5 35) and high grade (n 5 20) was
139.6 ( 35.2) mm3 and 222.9 ( 80.4) mm3, respectively. MNV of
grade II (n 5 39) and grade III (n 5 16) was 145.6 ( 38.6) mm3
and 229.0 ( 88.6) mm3, respectively (P !0.0001, ManneWhitney
U test). An optimal cut-off value of MNVO169 mm3 (81% sensitivity
and 78% specificity) was shown to differentiate MCTs with a more
aggressive behaviour (group 2).
Conclusions: The present study suggests that estimation of MNV on
routine histological sections may objectively improve the detection of
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Introduction: Feline invasive mammary carcinomas (FMCs) are
considered valuable immunocompetent animal models of breast can-
cer. Tumour-associated plasma cells have been associated with poor
prognosis in breast cancer, but have not been characterized in
FMCs. The aim of this study was to determine the amount and prog-
nostic value of peritumoural MUM1+ plasma cells in FMCs.
Materials and Methods: Retrospective study of 180 female cats
treated by surgery alone for an invasive mammary carcinoma, with
2-year follow-up. MUM1 (clone MRQ43), FoxP3 (clone SP97), oes-
trogen receptor (OR) (clone C311), progesterone receptor (PR)
(clone 10A9), Ki67 (clone MIB1) and HER2 (clone 4B5) expressions
were determined by automated immunohistochemistry. MUM1+
plasma cells and FoxP3+ regulatory T cells (Tregs) were quantitated
in intratumoural and peritumoural locations.
Results: Peritumoural plasma cell enrichment was positively associ-
ated with larger tumour size (10 mm; P 5 0.03), dermal infiltration
(P 5 0.006), and increasing numbers of intratumoural Tregs (P 5
0.001). By multivariate survival analysis, luminal (OR+ and/or
PR+) FMCs (57/180; 32%) with high numbers (O287/mm2) of peri-
tumoural plasma cells (43/57; 75%) were associated with shorter
overall survival (hazard ratio [HR] 5 2.56, 95% confidence interval
1.23e5.26) independently of PR expression (HR 5 0.40 for PR+
FMCs), and low nuclear polymorphism (HR 5 0.41; P 5 0.0001;
Cox proportional hazards regression). The negative impact of peritu-
moural plasma cells on overall survival was also observed in triple-
negative (ORe, PRe, HER2e) FMCs (123/180; 68%).
Conclusions: FMCs enriched in peritumoural plasma cells are en-
riched in Tregs, and associated with a worse outcome. They seem
promising animal models to test new cancer immunotherapy strate-
gies in an immunosuppressed tumour microenvironment.
